Adalsteinn Gunnlaugsson
1 – 51 of 51
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Morbiditet från urinvägar och tarm enligt registerdata efter ultrahypofraktionerad strålbehandling för lokaliserad prostatacancer vid 10 år i HYPO-RT-PC-studien
2024) Onkologidagarna 2024(
- Contribution to conference › Poster
-
Mark
Register data on long-term morbidity after prostate ultra-hypofractionation in the HYPO-RT-PC trial
(
- Contribution to conference › Abstract
-
Mark
Behandling av icke spridd prostatacancer – individuellt val
(
- Contribution to journal › Article
-
Mark
Evaluation of a deep learning magnetic resonance imaging reconstruction method for synthetic computed tomography generation in prostate radiotherapy
(
- Contribution to journal › Article
-
Mark
Dose-volume relationships of planned versus estimated delivered radiation doses to pelvic organs at risk and side effects in patients treated with salvage radiotherapy for recurrent prostate cancer
(
- Contribution to journal › Article
-
Mark
Ultrahypofractionated Radiation Therapy for Prostate Cancer Including Seminal Vesicles in the Target Volume : A Treatment-planning Study Based on the HYPO-RT-PC Fractionation Schedule
(
- Contribution to journal › Article
-
Mark
Register data on long-term morbidity after prostate cancer radiotherapy with ultra-hypofractionated (2.5 weeks) vs conventional (8 weeks) treatment schedules
2024) U21 Health Sciences Group 2024 Doctoral Student Forum(
- Contribution to conference › Poster
- 2023
-
Mark
Urosymphyseal fistula after pelvic radiotherapy in a tertial referral centre - a rare entity with significant comorbidity requiring multidisciplinary management
(
- Contribution to journal › Article
-
Mark
MRI-only radiotherapy from an economic perspective : Can new techniques in prostate cancer treatment be cost saving?
(
- Contribution to journal › Article
-
Mark
Risk of prostate cancer death after radical radiotherapy with neoadjuvant and adjuvant therapy with bicalutamide or gonadotropin-releasing hormone agonists
(
- Contribution to journal › Article
- 2022
-
Mark
A prospective phase II study of prostate-specific antigen-guided salvage radiotherapy and 68Ga-PSMA-PET for biochemical relapse after radical prostatectomy - The PROPER 1 trial
(
- Contribution to journal › Article
-
Mark
Dosimetric and Clinical Predictors for Acute and Late Gastrointestinal Toxicity Following Chemoradiotherapy of Locally Advanced Anal Cancer
(
- Contribution to journal › Article
- 2021
-
Mark
Adaptive sequential plan-on-plan optimization during prostate-specific antigen response guided radiotherapy of recurrent prostate cancer
(
- Contribution to journal › Article
-
Mark
Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer (HYPO-RT-PC) : patient-reported quality-of-life outcomes of a randomised, controlled, non-inferiority, phase 3 trial
(
- Contribution to journal › Article
-
Mark
Faster and more accurate patient positioning with surface guided radiotherapy for ultra-hypofractionated prostate cancer patients
(
- Contribution to journal › Article
-
Mark
Investigation of the clinical inter-observer bias in prostate fiducial marker image registration between CT and MR images
(
- Contribution to journal › Article
-
Mark
Long-Term Risk of Hip Complications After Radiation Therapy for Prostate Cancer : A Dose-Response Study
(
- Contribution to journal › Article
- 2020
-
Mark
Erectile Dysfunction and Absorbed Dose to Penile Base Structures in a Randomized Trial Comparing Ultrahypofractionated and Conventionally Fractionated Radiation Therapy for Prostate Cancer
(
- Contribution to journal › Article
-
Mark
Comparative Effectiveness of Different Radical Radiotherapy Treatment Regimens for Prostate Cancer : A Population-Based Cohort Study
(
- Contribution to journal › Article
-
Mark
MR-PROTECT : Clinical feasibility of a prostate MRI-only radiotherapy treatment workflow and investigation of acceptance criteria
(
- Contribution to journal › Article
-
Mark
PSA decay during salvage radiotherapy for prostate cancer as a predictor of disease outcome – 5 year follow-up of a prospective observational study
(
- Contribution to journal › Article
-
Mark
Dosimetric effects of adaptive prostate cancer radiotherapy in an MR-linac workflow
(
- Contribution to journal › Article
-
Mark
Patterns of recurrence in anal cancer : A detailed analysis
(
- Contribution to journal › Article
-
Mark
Treatment-related leukopenia in anal cancer patients associated with worse outcome : results of a retrospective cohort study
(
- Contribution to journal › Letter
-
Mark
Increased accuracy in reduced time – surface guided RT for hypofractionated prostate cancer patients
(
- Contribution to journal › Published meeting abstract
- 2019
-
Mark
Target definition in radiotherapy of prostate cancer using magnetic resonance imaging only workflow
(
- Contribution to journal › Article
-
Mark
Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer : 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial
(
- Contribution to journal › Article
-
Mark
Initial experience with introducing national Swedish guidelines for CT- and MRI-based delineation of organs at risk in radiotherapy
(
- Contribution to journal › Article
- 2018
-
Mark
MR and CT data with multiobserver delineations of organs in the pelvic area-Part of the Gold Atlas project
(
- Contribution to journal › Article
-
Mark
Prostate Cancer Death After Radiotherapy or Radical Prostatectomy : A Nationwide Population-based Observational Study
(
- Contribution to journal › Article
-
Mark
Determinants for local tumour control probability after radiotherapy of anal cancer
(
- Contribution to journal › Article
-
Mark
Using C-Arm X-ray images from marker insertion to confirm the gold fiducial marker identification in an MRI-only prostate radiotherapy workflow
(
- Contribution to journal › Article
-
Mark
Cone beam CT for QA of synthetic CT in MRI only for prostate patients
(
- Contribution to journal › Article
-
Mark
The effect of prostate motion during hypofractionated radiotherapy can be reduced by using flattening filter free beams
(
- Contribution to journal › Article
- 2017
-
Mark
MR-OPERA : A Multicenter/Multivendor Validation of Magnetic Resonance Imaging-Only Prostate Treatment Planning Using Synthetic Computed Tomography Images
(
- Contribution to journal › Article
-
Mark
Registration free automatic identification of gold fiducial markers in MRI target delineation images for prostate radiotherapy
(
- Contribution to journal › Article
-
Mark
Intensity-based dual model method for generation of synthetic CT images from standard T2-weighted MR images - Generalized technique for four different MR scanners
(
- Contribution to journal › Article
-
Mark
Prostate Cancer Radiation Therapy and Risk of Thromboembolic Events
(
- Contribution to journal › Article
- 2016
-
Mark
Very low rate of circulating tumour cells (CTCs) in patients with PSA recurrence after radical prostatectomy referred to salvage radiotherapy.
(
- Contribution to journal › Letter
-
Mark
Low-dose rate brachytherapy with I-125 seeds has an excellent 5-year outcome with few side effects in patients with low-risk prostate cancer
(
- Contribution to journal › Article
-
Mark
A national approach for automated collection of standardized and population-based radiation therapy data in Sweden
(
- Contribution to journal › Article
- 2015
-
Mark
Technical Note: MRI only prostate radiotherapy planning using the statistical decomposition algorithm.
(
- Contribution to journal › Article
-
Mark
Phase I study of cetuximab in combination with 5-fluorouracil, mitomycin C and radiotherapy in patients with locally advanced anal cancer.
(
- Contribution to journal › Article
- 2014
-
Mark
Change in prostate volume during extreme hypo-fractionation analysed with MRI.
(
- Contribution to journal › Article
-
Mark
Krabbamein í ristli og endaþarmi - yfirlitsgrein
(
- Contribution to journal › Scientific review
- 2013
-
Mark
Low rate of lymphedema after extended pelvic lymphadenectomy followed by pelvic irradiation of node-positive prostate cancer
(
- Contribution to journal › Article
- 2010
-
Mark
Chemoradiation in Gastrointestinal Cancer
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Multicentre phase I-II trial of capecitabine and oxaliplatin in combination with radiotherapy for unresectable pancreatic and biliary tract cancer: The CORGI-U study
(
- Contribution to journal › Article
- 2009
-
Mark
The effect on the small bowel of 5-FU and oxaliplatin in combination with radiation using a microcolony survival assay.
(
- Contribution to journal › Article
-
Mark
Multicentre phase II trial of capecitabine and oxaliplatin in combination with radiotherapy for unresectable colorectal cancer: The CORGI-L study.
(
- Contribution to journal › Article
- 2007
-
Mark
Dose-volume relationships between enteritis and irradiated bowel volumes during 5-fluorouracil and oxaliplatin based chemoradiotherapy in locally advanced rectal cancer
(
- Contribution to journal › Article